Bausch + Lomb (BLCO)
(Delayed Data from NYSE)
$15.53 USD
-0.64 (-3.96%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $15.52 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BLCO 15.53 -0.64(-3.96%)
Will BLCO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BLCO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLCO
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
BLCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
BLCO vs. AVTR: Which Stock Is the Better Value Option?
All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy
Other News for BLCO
Bausch Health price target lowered by $1 at Truist, here's why
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Strong Performance and Promising Outlook Justify Buy Rating for Bausch + Lomb
Bausch + Lomb price target raised by $2 at RBC Capital, here's why
Bausch + Lomb Corporation (BLCO) Gets a Buy from RBC Capital